OTC Phenylephrine is in the news!

Join Ashlee and David Brushwood as they navigate the convoluted world of OTC decongestants, and the pivotal roles pharmacists play in ensuring patient safety and medication efficacy.   

During this episode, the two discuss:
1. The role of the FDA in  managing GRASE, Generally Recognized as Safe and Effective, medications.
2. The FDA's original decision to include oral Phenylephrine products in the OTC monograph for decongestants.
3. The  CARES Act of 2020 and its impact on this efficacy and safety issue.
4. The instrumental roles of pharmacists in managing these products and providing the best options to patients. 

To access the FBA briefing document on the efficiency of Oral Phenylephrine as a nasal decongestant, click here. 

Follow CEimpact on Social Media:
LinkedIn
Instagram